These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 28423653)

  • 1. A novel microRNA signature predicts survival in stomach adenocarcinoma.
    Ding B; Gao X; Li H; Liu L; Hao X
    Oncotarget; 2017 Apr; 8(17):28144-28153. PubMed ID: 28423653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of microRNA expression profiles reveals a 5‑microRNA prognostic signature for predicting overall survival time in patients with gastric adenocarcinoma.
    Zhao R; Zhao L; Xu X; Xu H
    Oncol Rep; 2019 May; 41(5):2775-2789. PubMed ID: 30864737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Five-gene Signature based on MicroRNA for Predicting Prognosis and Immunotherapy in Stomach Adenocarcinoma.
    Wang T; Chen P; Li T; Li J; Zhao D; Meng F; Zhao Y; Zheng Z; Liu X
    Curr Med Chem; 2024; 31(17):2378-2399. PubMed ID: 38310388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma.
    Gao X; Wu Y; Yu W; Li H
    Oncotarget; 2016 Dec; 7(49):81670-81679. PubMed ID: 27835574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinoma.
    Li X; Shi Y; Yin Z; Xue X; Zhou B
    J Transl Med; 2014 Jun; 12():159. PubMed ID: 24893932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA signature predicts survival in papillary thyroid carcinoma.
    Chengfeng X; Gengming C; Junjia Z; Yunxia L
    J Cell Biochem; 2019 Oct; 120(10):17050-17058. PubMed ID: 31099134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets.
    Ren N; Liang B; Li Y
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of an immune-related gene prognostic model for stomach adenocarcinoma.
    Wu M; Xia Y; Wang Y; Fan F; Li X; Song J; Ding J
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33112406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of store-operated calcium entry-related gene signature for predicting prognosis and indicates immune microenvironment infiltration in stomach adenocarcinomas.
    Zhang Z; Wang C; Shi W; Wang Z; Fu W
    Sci Rep; 2024 Sep; 14(1):22342. PubMed ID: 39333689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome‑scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma.
    Wei HT; Guo EN; Liao XW; Chen LS; Wang JL; Ni M; Liang C
    Oncol Rep; 2018 Oct; 40(4):1947-1958. PubMed ID: 30066920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically applicable 53-Gene prognostic assay predicts chemotherapy benefit in gastric cancer: A multicenter study.
    Zhu L; Wang H; Jiang C; Li W; Zhai S; Cai X; Wang X; Liao L; Tao F; Jin D; Chen G; Xia Y; Mao JH; Li B; Wang P; Hang B
    EBioMedicine; 2020 Nov; 61():103023. PubMed ID: 33069062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Five-microRNA Signature for Survival Prognosis in Pancreatic Adenocarcinoma based on TCGA Data.
    Shi XH; Li X; Zhang H; He RZ; Zhao Y; Zhou M; Pan ST; Zhao CL; Feng YC; Wang M; Guo XJ; Qin RY
    Sci Rep; 2018 May; 8(1):7638. PubMed ID: 29769534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a novel prognostic signature in gastric adenocarcinoma.
    Mao R; Wang Z; Zhang Y; Chen Y; Liu Q; Zhang T; Liu Y
    Aging (Albany NY); 2020 Nov; 12(21):22233-22252. PubMed ID: 33188157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.
    Matsui D; Zaidi AH; Martin SA; Omstead AN; Kosovec JE; Huleihel L; Saldin LT; DiCarlo C; Silverman JF; Hoppo T; Finley GG; Badylak SF; Kelly RJ; Jobe BA
    Oncotarget; 2016 Dec; 7(49):81281-81291. PubMed ID: 27793030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of expression profile of miRNA in stomach adenocarcinoma.
    Huo Q
    J BUON; 2017; 22(5):1154-1159. PubMed ID: 29135097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a Four-miRNA Panel as a Biomarker for the Diagnosis of Stomach Adenocarcinoma.
    Chen X; Li X; Peng X; Zhang C; Liu K; Huang G; Lai Y
    Dis Markers; 2020; 2020():8880937. PubMed ID: 33224315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel microRNA signature predicts survival in liver hepatocellular carcinoma after hepatectomy.
    Fu Q; Yang F; Xiang T; Huai G; Yang X; Wei L; Yang H; Deng S
    Sci Rep; 2018 May; 8(1):7933. PubMed ID: 29785036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.